Spider Rock Advisors, LLC Royalty Pharma PLC Put Options Transaction History

Spider Rock Advisors, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 Apr 24, 2023	SELL	$32.77 - $39.4 $2.82 Million - $3.39 Million	-86,100 Reduced 46.17%	100,400 $3.47 Million
Q4 2022 Feb 07, 2023	SELL	$39.17 - $44.04 $2.1 Million - $2.36 Million	-53,500 Reduced 22.29%	186,500 $6.69 Million
Q3 2022 Nov 04, 2022	BUY	$39.88 - $44.65 $8.12 Million - $9.09 Million	203,500 Added 557.53%	240,000 $8.69 Million
Q2 2022 Aug 03, 2022	BUY	$37.53 - $44.22 $1.37 Million - $1.61 Million	36,500 New	36,500 $1.53 Million
Q4 2021 Feb 08, 2022	SELL	$35.17 - $42.48 $5.69 Million - $6.88 Million	-161,900 Closed	0 $0
Q3 2021 Oct 19, 2021	SELL	$36.14 - $42.24 $22.3 Million - $26.1 Million	-616,900 Reduced 79.21%	161,900 $6.48 Million
Q1 2021 May 12, 2021	BUY	$42.34 - $52.82 $33 Million - $41.1 Million	778,800 New	778,800 $34.2 Million

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Spider Rock Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Spider Rock Advisors, LLC with notifications on news.